SCHEMBL2601901

SCHEMBL2601901

Cc1cc(C)[n+](C)c(C)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.37
TSHR P16473 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.34
KDM4E B2RXH2 1/20 0.34
HTT P42858 1/20 0.34
ACHE P22303 2/20 0.33
SELL P14151 1/20 0.33
SELP P16109 1/20 0.33
SELE P16581 1/20 0.33
RAPGEF4 Q8WZA2 1/20 0.32
TP53 P04637 1/20 0.30
CYP3A4 P08684 1/20 0.30
THRB P10828 1/20 0.30
ALOX15 P16050 1/20 0.30
TDP1 Q9NUW8 1/20 0.30
CA12 O43570 1/20 0.30
CA1 P00915 1/20 0.30
CA2 P00918 1/20 0.30
CA7 P43166 1/20 0.30
CA9 Q16790 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL8748435 0.97 ALDH1A1 (0.35) ALDH1A1TSHRSMN1; SMN2KDM4EHTT
Bromide SCHEMBL11433606 0.97 ALDH1A1 (0.35) ALDH1A1TSHRSMN1; SMN2KDM4EHTT
Water SCHEMBL3791699 0.97 ALDH1A1 (0.35) ALDH1A1TSHRSMN1; SMN2KDM4EHTT
Hydrochloric Acid SCHEMBL7252277 0.97 KDM4E (0.38) ALDH1A1TSHRSMN1; SMN2KDM4EHTT
SCHEMBL5159873 0.79 KDM4E (0.50) ALDH1A1TSHRSMN1; SMN2KDM4EHTT
SCHEMBL10679825 0.74 IDO1 (0.31)
SCHEMBL18230630 0.73 GAA (0.45) ALDH1A1SMN1; SMN2RAPGEF4CYP3A4TDP1
SCHEMBL25447157 0.69 KDM4E (0.39) ALDH1A1SMN1; SMN2KDM4EHTTACHE
SCHEMBL138421 0.69 ALDH1A1 (0.35) ALDH1A1TSHRACHESELLSELP
SCHEMBL24775115 0.69 ALDH1A1 (0.40) ALDH1A1TSHRSMN1; SMN2KDM4EACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4405300-B1 EMM-63 ALUMINOSILICATE ZEOLITES, SYNTHESES, AND USES EXXONMOBIL TECHNOLOGY & ENGINEERING COMPANY (US) 2025-10-01 EP claimed
US-7837979-B2 Catalysis of a crystalline molecular sieve using 1,2,4,6-tetramethylpyridinium compound; adsorbent for gas separation EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2010-11-23 US claimed
WO-2008057430-A1 SYNTHESIS OF ITQ-12 EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2008-05-15 WO claimed
US-20080107594-A1 Synthesis of ITQ-12 EXXONMOBIL RESEARCH AND ENGINEERING COMPANY 2008-05-08 US claimed
US-4225497-A ACID CATALYSTS FOR IMIDATION RHONE-POULENC INDUSTRIES (FR) 1980-09-30 US claimed
US-20260018628-A1 FLUOROELASTOMER COMPOSITIONS FOR FUEL CELL SEALS SOLVAY SPECIALTY POLYMERS ITALY S.P.A. (IT) 2026-01-15 US disclosed
EP-4416216-B1 FLUOROELASTOMER COMPOSITION SYENSQO SPECIALTY POLYMERS ITALY S P A (IT) 2025-09-17 EP disclosed
EP-4555028-A1 CROSSLINKABLE FLUOROPOLYMER COMPOSITIONS FOR SEALING FUEL CELLS Solvay Specialty Polymers Italy S.p.A. (IT) 2025-05-21 EP disclosed
US-12247111-B2 Fluoroelastomer composition SOLVAY SPECIALTY POLYMERS ITALY S.P.A. (IT) 2025-03-11 US disclosed
CN-119546712-A Crosslinkable fluoropolymer compositions for sealing fuel cells 索尔维特殊聚合物意大利有限公司 2025-02-28 CN disclosed
US-20240409715-A1 FLUOROELASTOMER COMPOSITION SOLVAY SPECIALTY POLYMERS ITALY S.P.A. (IT) 2024-12-12 US disclosed
CN-113544205-B Fluoroelastomer composition 索尔维特殊聚合物意大利有限公司 2024-10-18 CN disclosed
US-20070190041-A1 Novel benzothiazepine and bensothiepine compounds ASHAI KASEI PHARAMA CORPORATION (JP) 2007-08-16 US disclosed
US-6241873-B1 SOLID ELECTROLYTE FORMED BY HEAT TREATING POLYMER HAVING QUATERNARY AMMONIUM GROUP IN ITS MAIN CHAIN AND HAVING HALIDE ION AS COUNTER ION, AND METAL HALIDE AT AT LEAST 100 DEGREES C. TDK CORPORATION (JP) 2001-06-05 US disclosed
EP-1056434-A1 DYEING METHOD USING A SPECIFIC CATIONIC DERIVATIVE AND A COMPOUND SELECTED AMONG A SPECIFIC ALDEHYDE, A SPECIFIC KETONE, A QUINONE AND A DI-IMINO-ISOINDOLINE OR 3-AMINO-ISOINDOLONE DERIVATIVE L'OREAL (FR) 2000-12-06 EP disclosed
WO-2000038639-A1 DYEING METHOD USING A SPECIFIC CATIONIC DERIVATIVE AND A COMPOUND SELECTED AMONG A SPECIFIC ALDEHYDE, A SPECIFIC KETONE, A QUINONE AND A DI-IMINO-ISOINDOLINE OR 3-AMINO-ISOINDOLONE DERIVATIVE L'OREAL (FR) 2000-07-06 WO disclosed
US-5273969-A A phosphonylmethylphosphoalkylaminoalkane derivative E. R. SQUIBB & SONS, INC. (US) 1993-12-28 US disclosed
US-5212164-A Hypocholesterolemic and antiatherosclerotic agents E. R. SQUIBB & SONS, INC. (US) 1993-05-18 US disclosed
EP-0409181-A2 Phosphorus-containing squalene synthetase inhibitors and method for their preparation E.R. SQUIBB & SONS, INC. (US) 1991-01-23 EP disclosed
US-4225497-A ACID CATALYSTS FOR IMIDATION RHONE-POULENC INDUSTRIES (FR) 1980-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260018628-A1 FLUOROELASTOMER COMPOSITIONS FOR FUEL CELL SEALS H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, FIS1, SUV39H1 ALDH1A1 3399/4885TSHR 1528/4885SMN1; SMN2 3141/4885
US-12247111-B2 Fluoroelastomer composition FLNA, BET1, FLNB ALDH1A1 4448/4885TSHR 4043/4885SMN1; SMN2 1722/4885
US-20070190041-A1 Novel benzothiazepine and bensothiepine compounds SLC10A1, GOT1, CES1 ALDH1A1 680/4885TSHR 2972/4885SMN1; SMN2 4351/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.